focus -WSS

focus

author：entertainment 2025-09-07 14:10:08 - browse：9713

Gavel and Stethoscope due process — District courts will make the first round of decisions soon on challenges to Medicare's drug price negotiation program. APStock

WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests.

District court judges could soon weigh in on the litany of court cases that major companies filed against the government — shedding light on whether drugmakers have any hope of postponing the first parts of the negotiation process, scrapping it entirely, or sending the issue up to the Supreme Court.

It’s a major moment for the Biden administration, too, as the White House ramps up its efforts to take credit for the new changes in the 2024 election. The first round of legal decisions will play out in the thick of campaign season, attorneys told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Tuberculosis patients need more than just free medication

leisure time

WSS

Doctors are clamoring for more clarity on Paxlovid prescribing

What health policies could hitch a ride on a spending bill?

Paxlovid rebound happens. Why and to whom are still a mystery

Tuberculosis patients need more than just free medication

Healthy food access boosts outcomes in two studies

Type 2 diabetes prevention programs work at large scale: study

focus

focus

explore

At least 13 dead in Texas as scorching temps continue

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Peter Hotez and the public health issue of online harassment

Today's health inequities arise from racist U.S. history, say experts

Medicare details structure of new drug price negotiation program

Kansas bar where gunfire wounded 9 last month closes permanently

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Sage considers ways to reduce costs following FDA rejection

Wikipedia

Google's generative AI to analyze medical images — and talk to docs

What health policies could hitch a ride on a spending bill?

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Weight loss drugs should be covered by insurers, AMA says

First transplant of an entire human eye performed

Ventyx halts psoriasis drug development after lackluster trial results

focus

focus

leisure time

Wikipedia